Risks and getting help

Check the product before the promise

Ask for the full product name, its source and the reason it is being proposed. If the answer stays vague, keep asking. The question is about what would be supplied to you, rather than how polished the service’s website looks. Take the written proposal to the clinician assessing your health, such as a doctor or nurse practitioner.

Drug quality

As of November 3, 2026, FDA has not approved compounded drugs. The checks FDA makes before approving a drug do not cover these compounded preparations.

FDA warns that poor compounding can let germs into a drug. It can also leave the strength higher or lower than intended.

In letters to sellers, FDA warns that injected drugs get past some of the body’s defenses that usually help block toxins and germs. Serious harm can result.

Look beyond labels and badges

As of the November 3, 2026 review, FDA warns against drugs sold for people to use despite labels saying they are research products. Such a label may read “for research purposes”; it may instead say “not for human consumption.” FDA does not know their quality and warns of possible harm.

The federal rule checked that date says a drug listing or business registration does not mean FDA approval.

If a service points to a badge or an entry in a drug directory, ask what that entry actually establishes. Then return to the clinician’s assessment and the proposed medicine. A badge does not answer what is in the prescription or who is responsible for the next conversation.

FDA flags online pharmacies that skip prescriptions or lack a license. No pharmacist to answer questions is another warning sign.

Match the pharmacy record

FDA records checked November 3, 2026 describe false pharmacy names on compounded tirzepatide and semaglutide products. In some cases the supposed pharmacy does not exist.

Get the name of the dispensing pharmacy, the business filling the prescription, from the service, then match it to the state record. Ask whom to contact if the name on a delivery does not match the name you were given. Keep the written answer.

Make storage and contact details part of the plan

Storage depends on the particular medicine; there is no rule that every peptide needs refrigeration.

Ask the pharmacist for the instructions that match the actual product. Ask how to handle a delayed delivery or unclear label. The answer needs to come from the people responsible for that medicine, rather than a general internet chart.

GLP-1 is a hormone involved in both appetite and the control of blood sugar. Medicines that copy its action include tirzepatide (Mounjaro, Zepbound). Another example is semaglutide (Ozempic, Wegovy).

For a GLP-1 injection delivered warm or with too little cooling, FDA advises against using it. The concern is drug quality.

FDA’s records checked November 3, 2026 include dose mistakes with compounded semaglutide. Some reports involved hospital stays.

Ask the prescriber and pharmacist to sort out any instructions that clash. Before leaving, ask what changes or symptoms mean it is time to call. Who takes that call? What is the plan when that person cannot be reached? Keep the reply with your other notes.

Keep urgent help within reach

A severe allergic reaction, called anaphylaxis, can develop quickly and threaten life.

Tongue swelling and difficulty breathing can be severe signs. MedlinePlus calls for emergency help, including 911, when severe allergic symptoms develop.

Get help for those severe symptoms; the cause needs assessment by someone who can care for you. Bring the medicine’s name and the information available about it when seeking care.

Reporting after care

People can report medicine problems directly through FDA MedWatch, its safety reporting program.

An unwanted experience can be reported without proof that the drug caused the problem. Reports alone do not supply that proof.

To raise a concern with Maryland’s physician board, use its complaint route for doctors and physician assistants. For a nurse practitioner, use the nursing board. Pharmacy concerns go to the pharmacy board.

Keep the product details, relevant dates and messages if you need to describe a problem. A complaint or report serves a different purpose from getting medical help; the care conversation still needs its own contact.